Plain Language Summary

Project: Sustained Reduction in Intact Parathyroid Hormone with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Patients with Secondary Hyperparathyroidism.

Client: Opko Health

Publisher: Karger

My role: Writer

Previous
Previous

Patient Insights Report: Endometrial Cancer

Next
Next

The Foot: From Evolution to Surgical Correction